Screener
Immucell ICCC Q1 2026 Annual earnings
Reported May 14, 2026 · After market close
Revenue$10.4MBeat by $5.0M
EPS$0.21Beat by $0.16
Revenue estimate$5.4M
EPS estimate$0.05
Next report
Date not yet announcedVersus estimates
Revenue
Q3 2026$8.0MBeat by $2.6MQ2 2026$7.2MBeat by $1.8M
Q1 2026$10.4MBeat by $5.0M
Q4 2025$7.6MBeat by $2.2MQ3 2025$5.5MQ2 2025$6.4MDiluted EPS
FAQ
- When did Immucell report Q1 2026 earnings?
- Immucell (ICCC) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were Immucell's Q1 2026 revenue and EPS?
- Immucell reported revenue of $10.4M and eps of $0.21 for Q1 2026.
- Did Immucell beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $5.4M by $5.0M. EPS beat the consensus estimate of $0.05 by $0.16.
- How did Immucell's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 28.4% from $8.1M a year earlier and eps grew 31.2% from $0.16.
- Where can I find Immucell's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-017049) and the 10-K/A periodic report (0001437749-26-016719) directly on SEC EDGAR. The filing index links above go to sec.gov.
